Christopher P. Kiritsy is Director at PIERIS PHARMACEUTICALS, INC. (PIRS). They have made 3 open-market trades across 2 companies since 2018, most recently 2026-09-02.
CIK 0001261156
2 open-market purchases totalling $34K since 2018, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PIRS | 20,000 | $272K |
| PVLA | 250 | $30K |
| Total | $302K |
Shares reported on the most recent Form 4, priced at the 2026-09-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.